Prophylactic use of ondansetron for emesis after craniofacial operations in children
dc.contributor.author | Gurler, T | |
dc.contributor.author | Celik, N | |
dc.contributor.author | Totan, S | |
dc.contributor.author | Songur, E | |
dc.contributor.author | Sakarya, M | |
dc.date.accessioned | 2019-10-27T11:51:10Z | |
dc.date.available | 2019-10-27T11:51:10Z | |
dc.date.issued | 1999 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Children who undergo craniofacial operations are especially at risk of postoperative nausea and vomiting. These operations are more complex than the craniotomies for resective procedures. Postoperative vomiting is a common occurrence that can delay recovery and result in cerebrospinal fluid leak acid fistula formation in these patients. Ondansetron, a selective serotonergic antagonist, is effective in reducing postoperative nausea and vomiting in several high-risk populations. In a randomized, double-blind, placebo-controlled study, the authors compared the prophylactic use of intravenous ondansetron 0.15 mg/kg with induction of anesthesia versus a placebo of normal saline 0.3 ml/kg with induction. A second dose was given 8 hours after the first dose. After surgery, episodes of vomiting were recorded separately in 0 to 2 hours, 2 to 6 hours, 6 to 12 hours, 12 to 24 hours, and 24 to 48 hours. Postoperative vomiting is significantly reduced in the ondansetron group compared with the placebo group (P = 0.000258). Ondansetron is effective in the prevention of postoperative vomiting in the pediatric population undergoing craniofacial operations. | en_US |
dc.identifier.endpage | 48 | en_US |
dc.identifier.issn | 1049-2275 | |
dc.identifier.issn | 1536-3732 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 10388426 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 45 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/34496 | |
dc.identifier.volume | 10 | en_US |
dc.identifier.wos | WOS:000077966200010 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Journal of Craniofacial Surgery | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | postoperative nausea and vomiting | en_US |
dc.subject | craniofacial surgery | en_US |
dc.title | Prophylactic use of ondansetron for emesis after craniofacial operations in children | en_US |
dc.type | Article | en_US |